2018
$38M
from 7 investors over 7 rounds
Nitrome Biosciences, Inc. raised $7M on November 2, 2021
Investors: Mission Bay Capital, Bristol-Myers Squibb, UK, The Dementia Discovery Fund and Sofinnova Partners
Nitrome Biosciences, Inc. raised $38M on April 22, 2020
Investors: Mission Bay Capital, Sofinnova Partners and The Dementia Discovery Fund